← Eichor
Study identifier: NCT06565247 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Condition: Prostate Cancer  ·  Sponsor: Region Västerbotten

PhasePhase 3
Planned participants60
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this trial the connection between image properties (mpMRI and PSMA-PET) and tissue properties (molecular and histopathology) will be investigated in order to improve diagnostics and image-based treatment guidance of prostate cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Camilla Thellenberg Karlsson, MD, PhD  ·  +46907850000  ·  camilla.thellenberg@umu.se

Tufve Nyholm, PhD  ·  +46907850000  ·  tufve.nyholm@umu.se

Always discuss trial participation with your own doctor first.

Locations (2)

Region SkåneMalmö, SwedenRecruiting
Region VästerbottenUmeå, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06565247